BioSpace News Archive

Business

Cullgen Announces Expanded Scientific Advisory Board

Cullgen Inc announced that Dr. Timothy Heffernan and Dr. Michele Pagano have joined the Company’s Scientific Advisory Board (SAB).

July 18, 2018
·
3 min read
FDA

FDA Grants Breakthrough Therapy Designation for Genentech’s TECENTRIQ in Combination With Avastin as First-Line Treatment for Advanced or Metastatic Hepatocellular Carcinoma (HCC)

Genentech announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for TECENTRIQ® (atezolizumab)

July 18, 2018
·
17 min read
Biotech Beach

Mesa Biotech to Showcase New Molecular POC Testing Platform at the 2018 AACC Scientific Meeting

Mesa Biotech Inc. announced it will showcase its novel Accula™ Flu A/Flu B test at the 70th Annual American Association of Clinical Chemistry Scientific Meeting & Clinical Lab Expo (AACC).

July 18, 2018
·
2 min read
Drug Development

Poxel Announces Favorable Results for PXL770 Phase 1b Multiple Ascending Dose Trial and Drug-Drug Interaction Study

PXL770 observed to have a favorable safety and pharmacokinetic profile in the complete Phase 1 program

July 18, 2018
·
7 min read
Business

Pall Corporation and KANEKA Corporation Expand Exclusive Distribution Agreement to Feature New KANEKA KanCapA™ 3G Protein A Chromatography Sorbents

Pall Corporation is pleased to announce the extension of a consumables distribution agreement with KANEKA Corporation.

July 18, 2018
·
3 min read
Pharm Country

Centivo, a New Type of Health Plan, Raises $34 Million in Series A Funding

Next Generation Self-Funded Health Plan Launched to Help Employers Deliver Affordable, Sustainable Healthcare for Their Employees

July 18, 2018
·
7 min read
Business

Sanofi and REVOLUTION Medicines Launch Global Partnership to Develop Potential First-in-Class Targeted Treatments for Multiple Cancers

Preclinical studies of SHP2 inhibitors demonstrated promise across multiple forms of cancer; lead drug candidate expected to start clinical trials in second half of 2018.

July 18, 2018
·
4 min read
Business

Alzheimer’s Therapeutics Research Leader Dr. Roy Twyman Joins NeuroVision Imaging Board

Twyman Served as Senior Vice President at Janssen Pharmaceutical Research & Development, Overseeing Alzheimer’s Disease Therapeutics.

July 18, 2018
·
6 min read
Drug Development

CTI BioPharma Announces Pacritinib Program Update Following Type B Meeting with U.S. FDA

Regulatory path to include Phase 3 trial expected to begin in 2019

July 18, 2018
·
6 min read
Business

Maxar Second Quarter 2018 Investor Call Scheduled for Tuesday, July 31

Maxar Technologies plans to release its second quarter 2018 financial results before the markets open on Tuesday, July 31, 2018.

July 18, 2018
·
3 min read